Bioequivalence Debate: ViroPharma Will Defend Vancocin At Advisory Cmte.

ViroPharma's Vancocin (vancomycin) isn't specifically on the agenda at the July 23 meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee, but the firm is treating the panel as a make-or-break event for the colitis treatment